Immunolocalization of β 2 -Glycoprotein I (Apolipoprotein H) to Human Atherosclerotic Plaques
Authors:
- 4 May 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (17) , 2227-2230
Abstract
Background —β 2 -Glycoprotein I (β2GPI) is a major antigenic target of antiphospholipid antibodies, which possesses natural anticoagulant properties. The aim of the present study was to determine its presence and localization within human atherosclerotic plaques and to study its association with endothelial cells and monocyte macrophages in vitro. Methods and Results —Human atherosclerotic lesions were obtained after carotid endarterectomies and studied immunohistochemically with anti-β2GPI as well as antibodies to CD4/CD8, macrophages, and adhesion molecules. In vitro, human umbilical vein endothelial cells (HUVECs) and U937 (myelomonocytic cell line) cells were investigated for their ability to associate with radiolabeled β2GPI. We found β2GPI to be abundantly expressed within the subendothelial regions and intimal-medial borders of human atherosclerotic plaques and to colocalize with CD4-positive lymphocytes. This observation was confirmed by Western blot applied on homogenates of atherosclerotic lesions with anti-β2GPI antibodies. Both HUVECs and U937 cells bound labeled β2GPI, and the process was inhibited by oxidized LDL and not by native LDL. Conclusions —The abundant presence of human β2GPI within the lesions, its association with endothelial cells and macrophages, and its colocalization with CD4-positive lymphocytes suggests that it may serve as a target for an immune-mediated reaction that can influence lesion progression.Keywords
This publication has 11 references indexed in Scilit:
- Differential Effects of Anti–β 2 -Glycoprotein I Antibodies on Endothelial Cells and on the Manifestations of Experimental Antiphospholipid SyndromeCirculation, 1998
- Involvement of beta2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophagesClinical and Experimental Immunology, 1997
- Immunology of the antiphospholipid antibody syndromeArthritis & Rheumatism, 1996
- Activation of cultured vascular endothelial cells by antiphospholipid antibodies.Journal of Clinical Investigation, 1995
- T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.Proceedings of the National Academy of Sciences, 1995
- Is atherosclerosis an immunologically mediated disease?Immunology Today, 1995
- The oxidation hypothesis of atherosclerosisThe Lancet, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).Journal of Clinical Investigation, 1992
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973